Search filters

List of works by Tejas Patil

Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung.

scientific article published on 23 August 2017

Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer

scientific article published on 21 November 2019

Complications of Androgen Deprivation Therapy in Men With Prostate Cancer

scientific article published on 01 September 2018

Detection of oligoprogressive disease in oncogene-addicted non-small cell lung cancer using PET/CT versus CT in patients receiving a tyrosine kinase inhibitor

scientific article published on 23 October 2018

Epidemiology and treatment trends for primary tracheal squamous cell carcinoma

scientific article published on 12 April 2019

First-line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non-Small-cell Lung Cancer With Different Prognostic Significance

scientific article published on 22 August 2018

Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status

scientific article published on 26 March 2016

Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis

scientific article

Miliary Metastases in Non-Small-Cell Lung Cancer

scientific article published on 01 November 2018

Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with oncogene-driven non-small cell lung cancer

scientific article published on 11 December 2018

ROS1 Gene Rearrangements Are Associated With an Elevated Risk of Peridiagnosis Thromboembolic Events

scientific article published on 10 December 2018

Reduced Smad4 expression and DNA topoisomerase inhibitor chemosensitivity in non-small cell lung cancer.

scientific article published on 25 April 2017

Targeted therapies for ROS1-rearranged non-small cell lung cancer

scientific article published on 01 October 2019

The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non-Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib

scientific article published on 05 July 2018

Untapped potential: recognising CNS opportunities in early oncology drug development

scientific article published on 03 October 2019